Skip to main content
. 2017 Nov 28;2017(11):CD003898. doi: 10.1002/14651858.CD003898.pub6

Comparison 3. MgSO4 versus SABA.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Clinical severity score 3 93 Mean Difference (IV, Fixed, 95% CI) ‐0.13 [‐0.62, 0.36]
1.1 Fischl index final score (120 mins) 1 33 Mean Difference (IV, Fixed, 95% CI) ‐0.33 [‐1.07, 0.41]
1.2 Fischl index score (time point unclear) 1 40 Mean Difference (IV, Fixed, 95% CI) ‐0.20 [‐1.11, 0.71]
1.3 Change in Fischl index at 120 mins 1 20 Mean Difference (IV, Fixed, 95% CI) 0.30 [‐0.67, 1.27]
2 Admission to hospital 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
3 Heart rate (120 mins) 1 20 Mean Difference (IV, Fixed, 95% CI) 21.20 [0.17, 42.23]
4 Respiratory rate 2 60 Mean Difference (IV, Fixed, 95% CI) ‐2.40 [‐3.91, ‐0.89]
5 Systolic pressure (120 mins) 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
6 Diastolic pressure (120 mins) 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
7 Serious adverse events 2 53 Risk Difference (M‐H, Fixed, 95% CI) 0.0 [‐0.10, 0.10]
8 Mild‐Moderate Side Effects 1   Risk Difference (M‐H, Fixed, 95% CI) Totals not selected